Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arsenic | 51 | 2022 | 251 | 10.660 |
Why?
|
Water Pollutants, Chemical | 23 | 2022 | 135 | 4.120 |
Why?
|
Environmental Exposure | 31 | 2022 | 296 | 3.830 |
Why?
|
Arsenic Poisoning | 15 | 2019 | 103 | 3.160 |
Why?
|
Bangladesh | 54 | 2021 | 318 | 2.760 |
Why?
|
Environmental Pollutants | 7 | 2022 | 51 | 2.420 |
Why?
|
Oryza | 5 | 2021 | 40 | 1.900 |
Why?
|
DNA Methylation | 9 | 2019 | 628 | 1.800 |
Why?
|
Drinking Water | 10 | 2022 | 64 | 1.790 |
Why?
|
Maternal Exposure | 6 | 2021 | 57 | 1.770 |
Why?
|
Skin Diseases | 13 | 2019 | 166 | 1.590 |
Why?
|
Diet | 8 | 2019 | 443 | 1.580 |
Why?
|
Metals | 4 | 2022 | 90 | 1.380 |
Why?
|
Polymorphism, Single Nucleotide | 20 | 2021 | 2357 | 1.290 |
Why?
|
Cohort Studies | 25 | 2023 | 2767 | 1.270 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2021 | 153 | 1.250 |
Why?
|
Middle Aged | 72 | 2023 | 25028 | 1.190 |
Why?
|
Pregnancy Outcome | 2 | 2020 | 247 | 1.190 |
Why?
|
Water Supply | 12 | 2022 | 60 | 1.170 |
Why?
|
Female | 87 | 2023 | 44532 | 1.170 |
Why?
|
Cacodylic Acid | 4 | 2021 | 22 | 1.150 |
Why?
|
Lung | 4 | 2021 | 1170 | 1.130 |
Why?
|
Nutrition Surveys | 7 | 2022 | 114 | 1.110 |
Why?
|
Vital Capacity | 4 | 2021 | 64 | 1.100 |
Why?
|
Adult | 70 | 2023 | 25648 | 1.070 |
Why?
|
Blood Pressure | 8 | 2020 | 1143 | 1.050 |
Why?
|
Groundwater | 2 | 2022 | 10 | 1.040 |
Why?
|
Humans | 111 | 2023 | 86643 | 1.020 |
Why?
|
Metals, Heavy | 3 | 2019 | 15 | 1.010 |
Why?
|
Gene-Environment Interaction | 4 | 2018 | 103 | 0.960 |
Why?
|
Male | 74 | 2022 | 40965 | 0.960 |
Why?
|
Asthma | 2 | 2021 | 955 | 0.910 |
Why?
|
Allostasis | 1 | 2023 | 2 | 0.910 |
Why?
|
Epigenesis, Genetic | 4 | 2019 | 479 | 0.900 |
Why?
|
Genetic Predisposition to Disease | 14 | 2021 | 2271 | 0.880 |
Why?
|
Occupational Exposure | 3 | 2018 | 80 | 0.870 |
Why?
|
Cardiovascular Diseases | 9 | 2021 | 827 | 0.850 |
Why?
|
Forced Expiratory Volume | 2 | 2021 | 122 | 0.850 |
Why?
|
Aged | 43 | 2023 | 18415 | 0.780 |
Why?
|
Selenium | 3 | 2019 | 44 | 0.780 |
Why?
|
Pesticides | 4 | 2020 | 29 | 0.770 |
Why?
|
Prospective Studies | 25 | 2020 | 4213 | 0.770 |
Why?
|
Gravidity | 1 | 2020 | 7 | 0.770 |
Why?
|
Environmental Monitoring | 6 | 2021 | 71 | 0.760 |
Why?
|
Metabolic Syndrome | 2 | 2018 | 141 | 0.730 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2017 | 689 | 0.730 |
Why?
|
Smoking | 8 | 2019 | 609 | 0.720 |
Why?
|
Genome-Wide Association Study | 14 | 2021 | 1621 | 0.700 |
Why?
|
Hypertension | 5 | 2019 | 1141 | 0.690 |
Why?
|
Cardiotoxins | 1 | 2018 | 3 | 0.690 |
Why?
|
Residence Characteristics | 1 | 2020 | 197 | 0.680 |
Why?
|
Manganese | 1 | 2019 | 53 | 0.680 |
Why?
|
Young Adult | 31 | 2021 | 5976 | 0.680 |
Why?
|
Food | 3 | 2015 | 86 | 0.670 |
Why?
|
Food Contamination | 5 | 2019 | 31 | 0.660 |
Why?
|
Adolescent | 32 | 2021 | 8981 | 0.660 |
Why?
|
Pregnancy | 8 | 2022 | 2894 | 0.660 |
Why?
|
Child | 11 | 2023 | 6927 | 0.650 |
Why?
|
Cross-Sectional Studies | 10 | 2021 | 1621 | 0.650 |
Why?
|
Risk Factors | 20 | 2022 | 5417 | 0.630 |
Why?
|
Child Mortality | 1 | 2017 | 5 | 0.620 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2017 | 16 | 0.620 |
Why?
|
Telomere | 4 | 2021 | 108 | 0.620 |
Why?
|
Urinalysis | 1 | 2017 | 33 | 0.610 |
Why?
|
Longitudinal Studies | 17 | 2021 | 1019 | 0.600 |
Why?
|
Obesity | 3 | 2021 | 963 | 0.600 |
Why?
|
Diet, Gluten-Free | 1 | 2017 | 52 | 0.590 |
Why?
|
Birth Weight | 3 | 2022 | 145 | 0.570 |
Why?
|
Arsenicals | 5 | 2019 | 48 | 0.560 |
Why?
|
Antioxidants | 3 | 2013 | 223 | 0.550 |
Why?
|
Carcinogens | 1 | 2016 | 108 | 0.550 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 1373 | 0.540 |
Why?
|
Lung Diseases | 2 | 2016 | 263 | 0.540 |
Why?
|
Selenomethionine | 2 | 2013 | 11 | 0.540 |
Why?
|
Proportional Hazards Models | 6 | 2020 | 859 | 0.530 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2017 | 137 | 0.520 |
Why?
|
Telomere Homeostasis | 3 | 2021 | 30 | 0.520 |
Why?
|
Skin Neoplasms | 4 | 2019 | 546 | 0.520 |
Why?
|
Quantitative Trait Loci | 5 | 2021 | 576 | 0.500 |
Why?
|
Mendelian Randomization Analysis | 3 | 2021 | 43 | 0.490 |
Why?
|
CpG Islands | 5 | 2019 | 151 | 0.480 |
Why?
|
Breast Neoplasms | 8 | 2019 | 2903 | 0.480 |
Why?
|
Gene Expression | 2 | 2018 | 1284 | 0.480 |
Why?
|
Public Health | 3 | 2022 | 129 | 0.480 |
Why?
|
Water Wells | 4 | 2022 | 18 | 0.470 |
Why?
|
Digestive System Neoplasms | 1 | 2013 | 20 | 0.460 |
Why?
|
alpha-Tocopherol | 1 | 2013 | 9 | 0.460 |
Why?
|
Anticarcinogenic Agents | 1 | 2013 | 70 | 0.440 |
Why?
|
United States | 10 | 2022 | 6672 | 0.420 |
Why?
|
Methyltransferases | 3 | 2019 | 182 | 0.420 |
Why?
|
Water Pollution, Chemical | 3 | 2011 | 21 | 0.420 |
Why?
|
Body Mass Index | 8 | 2018 | 770 | 0.420 |
Why?
|
Genome, Human | 5 | 2019 | 756 | 0.410 |
Why?
|
Vitamin B Complex | 1 | 2010 | 21 | 0.370 |
Why?
|
Ammonia-Lyases | 2 | 2019 | 6 | 0.350 |
Why?
|
Glutamate Formimidoyltransferase | 2 | 2019 | 6 | 0.350 |
Why?
|
Genotype | 8 | 2019 | 1851 | 0.350 |
Why?
|
Gestational Age | 2 | 2021 | 311 | 0.350 |
Why?
|
Genetic Variation | 4 | 2021 | 1351 | 0.340 |
Why?
|
Infant | 3 | 2021 | 3046 | 0.330 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2015 | 1197 | 0.330 |
Why?
|
Genotyping Techniques | 3 | 2019 | 68 | 0.320 |
Why?
|
Phenotype | 8 | 2021 | 2378 | 0.320 |
Why?
|
Loss of Heterozygosity | 1 | 2008 | 85 | 0.320 |
Why?
|
Infant, Newborn | 4 | 2020 | 2379 | 0.320 |
Why?
|
Chicago | 3 | 2021 | 1379 | 0.310 |
Why?
|
Parity | 2 | 2020 | 93 | 0.310 |
Why?
|
Gene Amplification | 1 | 2008 | 131 | 0.310 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 1920 | 0.310 |
Why?
|
Mortality | 3 | 2017 | 149 | 0.290 |
Why?
|
Odds Ratio | 6 | 2019 | 678 | 0.290 |
Why?
|
Social Class | 1 | 2007 | 128 | 0.290 |
Why?
|
Chromosome Aberrations | 1 | 2008 | 387 | 0.290 |
Why?
|
Neoplasms | 4 | 2022 | 2898 | 0.290 |
Why?
|
Gene Expression Profiling | 4 | 2014 | 1384 | 0.280 |
Why?
|
Leukocytes | 2 | 2018 | 202 | 0.270 |
Why?
|
Prevalence | 7 | 2018 | 1239 | 0.260 |
Why?
|
Biomarkers | 5 | 2017 | 1718 | 0.260 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 1721 | 0.250 |
Why?
|
Sex Factors | 4 | 2018 | 1054 | 0.250 |
Why?
|
Lymphocytes | 1 | 2006 | 464 | 0.240 |
Why?
|
Smoking Cessation | 2 | 2019 | 230 | 0.240 |
Why?
|
Aging | 3 | 2023 | 691 | 0.240 |
Why?
|
Cadmium | 3 | 2022 | 28 | 0.230 |
Why?
|
Apolipoprotein E4 | 1 | 2023 | 27 | 0.230 |
Why?
|
Multifunctional Enzymes | 2 | 2019 | 6 | 0.220 |
Why?
|
Child, Preschool | 3 | 2021 | 3612 | 0.220 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 567 | 0.220 |
Why?
|
United Kingdom | 1 | 2023 | 164 | 0.220 |
Why?
|
Precancerous Conditions | 3 | 2010 | 196 | 0.210 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 65 | 0.210 |
Why?
|
Population Health | 1 | 2022 | 33 | 0.210 |
Why?
|
Molybdenum | 1 | 2022 | 12 | 0.210 |
Why?
|
Thinness | 2 | 2014 | 43 | 0.210 |
Why?
|
Copper | 1 | 2022 | 71 | 0.210 |
Why?
|
Respiration Disorders | 2 | 2013 | 39 | 0.210 |
Why?
|
Blood Cells | 1 | 2021 | 33 | 0.200 |
Why?
|
Databases, Genetic | 3 | 2019 | 260 | 0.200 |
Why?
|
Telomere Shortening | 1 | 2021 | 23 | 0.200 |
Why?
|
Incidence | 5 | 2018 | 1577 | 0.200 |
Why?
|
Regression Analysis | 4 | 2017 | 596 | 0.200 |
Why?
|
Biomarkers, Tumor | 4 | 2018 | 1464 | 0.200 |
Why?
|
Cognitive Dysfunction | 1 | 2023 | 132 | 0.190 |
Why?
|
Life Style | 2 | 2018 | 189 | 0.190 |
Why?
|
Water Purification | 1 | 2020 | 3 | 0.190 |
Why?
|
beta-Globins | 1 | 2019 | 2 | 0.180 |
Why?
|
Blood | 1 | 2019 | 69 | 0.180 |
Why?
|
Whole Genome Sequencing | 1 | 2019 | 76 | 0.180 |
Why?
|
Receptor, EphA4 | 1 | 2019 | 5 | 0.180 |
Why?
|
Insulin Resistance | 1 | 2022 | 377 | 0.170 |
Why?
|
Case-Control Studies | 6 | 2018 | 1805 | 0.170 |
Why?
|
Genes, Mitochondrial | 1 | 2018 | 9 | 0.170 |
Why?
|
Alzheimer Disease | 1 | 2023 | 470 | 0.170 |
Why?
|
Receptors, Opioid | 1 | 2019 | 24 | 0.170 |
Why?
|
Metabolism | 1 | 2018 | 24 | 0.170 |
Why?
|
Acculturation | 1 | 2018 | 14 | 0.170 |
Why?
|
Tobacco Smoking | 1 | 2019 | 25 | 0.170 |
Why?
|
Ions | 1 | 2019 | 74 | 0.170 |
Why?
|
Aged, 80 and over | 6 | 2020 | 6509 | 0.170 |
Why?
|
Genetic Testing | 1 | 2022 | 535 | 0.160 |
Why?
|
Air Pollution | 1 | 2019 | 68 | 0.160 |
Why?
|
Air Pollutants | 1 | 2019 | 78 | 0.160 |
Why?
|
Exercise | 2 | 2021 | 315 | 0.160 |
Why?
|
Muscle Contraction | 1 | 2019 | 283 | 0.160 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 183 | 0.160 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2019 | 231 | 0.160 |
Why?
|
Waist-Height Ratio | 1 | 2017 | 1 | 0.160 |
Why?
|
Atlases as Topic | 1 | 2017 | 7 | 0.160 |
Why?
|
Abortion, Therapeutic | 1 | 2017 | 11 | 0.160 |
Why?
|
Stillbirth | 1 | 2017 | 9 | 0.160 |
Why?
|
Epistasis, Genetic | 1 | 2018 | 86 | 0.150 |
Why?
|
Solvents | 1 | 2017 | 96 | 0.150 |
Why?
|
Naltrexone | 1 | 2019 | 135 | 0.150 |
Why?
|
Dietary Exposure | 1 | 2017 | 2 | 0.150 |
Why?
|
Chromosomes, Human | 1 | 2017 | 66 | 0.150 |
Why?
|
Narcotic Antagonists | 1 | 2019 | 154 | 0.150 |
Why?
|
DNA Helicases | 1 | 2017 | 79 | 0.150 |
Why?
|
Surveys and Questionnaires | 3 | 2022 | 2501 | 0.150 |
Why?
|
Abortion, Spontaneous | 1 | 2017 | 66 | 0.150 |
Why?
|
Transcriptome | 1 | 2021 | 580 | 0.150 |
Why?
|
Drinking | 3 | 2011 | 34 | 0.150 |
Why?
|
Depressive Disorder | 1 | 2017 | 218 | 0.140 |
Why?
|
Age Factors | 2 | 2018 | 1851 | 0.140 |
Why?
|
Creatinine | 1 | 2017 | 338 | 0.140 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 171 | 0.140 |
Why?
|
Parents | 1 | 2018 | 272 | 0.140 |
Why?
|
Areca | 2 | 2013 | 9 | 0.140 |
Why?
|
Heart Diseases | 2 | 2016 | 290 | 0.130 |
Why?
|
Follow-Up Studies | 4 | 2018 | 3640 | 0.130 |
Why?
|
Lead | 1 | 2015 | 26 | 0.130 |
Why?
|
Precision Medicine | 1 | 2019 | 395 | 0.130 |
Why?
|
Dyspnea | 1 | 2016 | 73 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 1 | 2015 | 50 | 0.130 |
Why?
|
Anxiety Disorders | 1 | 2016 | 148 | 0.130 |
Why?
|
Mitochondria | 1 | 2018 | 535 | 0.130 |
Why?
|
Fetal Blood | 1 | 2015 | 90 | 0.130 |
Why?
|
Proteinuria | 1 | 2015 | 107 | 0.130 |
Why?
|
Developing Countries | 1 | 2015 | 71 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 70 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2013 | 1961 | 0.130 |
Why?
|
Illinois | 1 | 2016 | 462 | 0.130 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 329 | 0.120 |
Why?
|
Phosphofructokinase-1, Muscle Type | 1 | 2014 | 9 | 0.120 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 288 | 0.120 |
Why?
|
Chondromatosis | 1 | 1993 | 2 | 0.120 |
Why?
|
Leiomyoma, Epithelioid | 1 | 1993 | 2 | 0.120 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 1993 | 12 | 0.120 |
Why?
|
Anxiety | 1 | 2016 | 287 | 0.120 |
Why?
|
Depression | 1 | 2017 | 473 | 0.120 |
Why?
|
Arm | 1 | 2014 | 91 | 0.120 |
Why?
|
Mediastinal Neoplasms | 1 | 1993 | 46 | 0.120 |
Why?
|
Multifactorial Inheritance | 1 | 2015 | 159 | 0.110 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1993 | 100 | 0.110 |
Why?
|
Overweight | 1 | 2014 | 118 | 0.110 |
Why?
|
Vitamin E | 2 | 2014 | 35 | 0.110 |
Why?
|
Keratosis | 1 | 2012 | 21 | 0.110 |
Why?
|
Urinary Bladder | 1 | 2015 | 246 | 0.110 |
Why?
|
Models, Statistical | 1 | 2016 | 574 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 427 | 0.110 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2012 | 47 | 0.110 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 296 | 0.110 |
Why?
|
Alleles | 4 | 2019 | 1128 | 0.100 |
Why?
|
Tremor | 1 | 2011 | 22 | 0.100 |
Why?
|
Essential Tremor | 1 | 2011 | 6 | 0.100 |
Why?
|
Methylation | 3 | 2019 | 251 | 0.100 |
Why?
|
Double-Blind Method | 2 | 2013 | 1823 | 0.100 |
Why?
|
Tissue Fixation | 1 | 2010 | 40 | 0.100 |
Why?
|
Skin | 1 | 2014 | 554 | 0.100 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 383 | 0.100 |
Why?
|
Stomach Neoplasms | 1 | 1993 | 266 | 0.100 |
Why?
|
Paraffin Embedding | 1 | 2010 | 78 | 0.100 |
Why?
|
Formaldehyde | 1 | 2010 | 52 | 0.100 |
Why?
|
Protective Agents | 1 | 2010 | 33 | 0.090 |
Why?
|
MicroRNAs | 1 | 2015 | 534 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2022 | 508 | 0.090 |
Why?
|
Population Surveillance | 1 | 2011 | 219 | 0.090 |
Why?
|
Water | 1 | 2011 | 277 | 0.090 |
Why?
|
Health Surveys | 2 | 2011 | 239 | 0.090 |
Why?
|
DNA | 1 | 2014 | 1294 | 0.080 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2008 | 42 | 0.080 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2008 | 79 | 0.080 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2008 | 85 | 0.080 |
Why?
|
Protein Carbonylation | 1 | 2008 | 10 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2008 | 100 | 0.080 |
Why?
|
Gene Frequency | 2 | 2019 | 677 | 0.080 |
Why?
|
Gene Dosage | 1 | 2008 | 207 | 0.080 |
Why?
|
Rural Population | 3 | 2014 | 136 | 0.070 |
Why?
|
Ownership | 1 | 2007 | 26 | 0.070 |
Why?
|
Sex Characteristics | 2 | 2019 | 319 | 0.070 |
Why?
|
Chronic Disease | 1 | 2010 | 971 | 0.070 |
Why?
|
Population Groups | 1 | 2006 | 41 | 0.070 |
Why?
|
Cause of Death | 3 | 2013 | 277 | 0.070 |
Why?
|
Risk Assessment | 3 | 2018 | 2261 | 0.070 |
Why?
|
Chromosome Mapping | 1 | 2008 | 1074 | 0.060 |
Why?
|
Computer Simulation | 2 | 2022 | 1078 | 0.060 |
Why?
|
Vegetables | 2 | 2015 | 45 | 0.060 |
Why?
|
Demography | 2 | 2015 | 177 | 0.060 |
Why?
|
Age of Onset | 2 | 2017 | 310 | 0.050 |
Why?
|
Income | 1 | 2022 | 75 | 0.050 |
Why?
|
Research Design | 1 | 2006 | 594 | 0.050 |
Why?
|
Insulins | 1 | 2022 | 6 | 0.050 |
Why?
|
Texas | 1 | 2022 | 101 | 0.050 |
Why?
|
Mexican Americans | 1 | 2022 | 63 | 0.050 |
Why?
|
Animals | 2 | 2019 | 26582 | 0.050 |
Why?
|
Thyrotropin | 1 | 2022 | 280 | 0.050 |
Why?
|
Lung Neoplasms | 1 | 1993 | 2262 | 0.050 |
Why?
|
Accelerometry | 1 | 2021 | 36 | 0.050 |
Why?
|
Triiodothyronine | 1 | 2022 | 339 | 0.050 |
Why?
|
Thyroxine | 1 | 2022 | 344 | 0.050 |
Why?
|
Michigan | 1 | 2020 | 52 | 0.050 |
Why?
|
Thyroid Hormones | 1 | 2022 | 321 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2018 | 18 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2022 | 319 | 0.040 |
Why?
|
Folic Acid | 1 | 2019 | 60 | 0.040 |
Why?
|
Machine Learning | 1 | 2021 | 232 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2019 | 132 | 0.040 |
Why?
|
Health Education | 1 | 2019 | 101 | 0.040 |
Why?
|
Linkage Disequilibrium | 1 | 2019 | 473 | 0.040 |
Why?
|
Estrogens | 1 | 2019 | 200 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2017 | 8 | 0.040 |
Why?
|
Glutathione Transferase | 1 | 2018 | 111 | 0.040 |
Why?
|
Blood Glucose | 1 | 2022 | 873 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2017 | 83 | 0.040 |
Why?
|
Adipocytes | 1 | 2018 | 155 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2019 | 276 | 0.040 |
Why?
|
Breast | 1 | 2019 | 288 | 0.040 |
Why?
|
Adiposity | 1 | 2017 | 70 | 0.040 |
Why?
|
Longevity | 1 | 2017 | 51 | 0.040 |
Why?
|
Receptors, Progesterone | 1 | 2018 | 167 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 547 | 0.040 |
Why?
|
Triglycerides | 1 | 2017 | 232 | 0.040 |
Why?
|
Mutation | 1 | 2008 | 3968 | 0.040 |
Why?
|
Genetics, Population | 1 | 2019 | 394 | 0.040 |
Why?
|
Computational Biology | 1 | 2019 | 528 | 0.040 |
Why?
|
Dyslipidemias | 1 | 2017 | 109 | 0.040 |
Why?
|
Time Factors | 2 | 2015 | 5210 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 2018 | 384 | 0.030 |
Why?
|
Self Report | 1 | 2017 | 288 | 0.030 |
Why?
|
Glucose | 1 | 2018 | 638 | 0.030 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2015 | 20 | 0.030 |
Why?
|
Fruit | 1 | 2015 | 75 | 0.030 |
Why?
|
Asia | 1 | 2014 | 95 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 937 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 303 | 0.030 |
Why?
|
Data Collection | 2 | 2006 | 372 | 0.030 |
Why?
|
Chemoprevention | 1 | 2014 | 91 | 0.030 |
Why?
|
Comorbidity | 1 | 2018 | 943 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 128 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2015 | 273 | 0.030 |
Why?
|
Poverty | 1 | 2015 | 173 | 0.030 |
Why?
|
Causality | 1 | 2013 | 81 | 0.030 |
Why?
|
Spectrophotometry, Atomic | 1 | 2013 | 12 | 0.030 |
Why?
|
Inflammation | 1 | 2019 | 920 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 182 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 297 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 860 | 0.030 |
Why?
|
Insulin | 1 | 2018 | 1160 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 136 | 0.030 |
Why?
|
Survival Analysis | 1 | 2017 | 1538 | 0.030 |
Why?
|
Disease Progression | 1 | 2018 | 1531 | 0.030 |
Why?
|
Organ Size | 1 | 2014 | 364 | 0.030 |
Why?
|
Blotting, Western | 1 | 2015 | 782 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 552 | 0.030 |
Why?
|
Syndrome | 1 | 1993 | 446 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 879 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2013 | 188 | 0.030 |
Why?
|
Genomics | 1 | 2018 | 720 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 3092 | 0.030 |
Why?
|
Tobacco, Smokeless | 1 | 2011 | 10 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 315 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2015 | 819 | 0.030 |
Why?
|
Food Analysis | 1 | 2011 | 4 | 0.030 |
Why?
|
Community Health Planning | 1 | 2011 | 21 | 0.020 |
Why?
|
Cucurbitaceae | 1 | 2010 | 4 | 0.020 |
Why?
|
Cell Movement | 1 | 2015 | 758 | 0.020 |
Why?
|
Fertilizers | 1 | 2010 | 8 | 0.020 |
Why?
|
Mastication | 1 | 2011 | 76 | 0.020 |
Why?
|
Sunlight | 1 | 2010 | 26 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 806 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2010 | 37 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2011 | 319 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 307 | 0.020 |
Why?
|
Prognosis | 1 | 2018 | 3679 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 59 | 0.020 |
Why?
|
Epidemiological Monitoring | 1 | 2010 | 39 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2010 | 155 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 258 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2010 | 369 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2015 | 2818 | 0.020 |
Why?
|
Down-Regulation | 1 | 2010 | 504 | 0.020 |
Why?
|
Respiratory Tract Diseases | 1 | 2009 | 45 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2015 | 1981 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2015 | 1578 | 0.020 |
Why?
|
Intelligence | 1 | 2009 | 71 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2010 | 912 | 0.020 |
Why?
|
Signal Transduction | 1 | 2019 | 3241 | 0.020 |
Why?
|
Apoptosis | 1 | 2015 | 1683 | 0.020 |
Why?
|
Up-Regulation | 1 | 2010 | 712 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2009 | 151 | 0.020 |
Why?
|
Appendicitis | 1 | 1988 | 62 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2008 | 128 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2008 | 373 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2019 | 7993 | 0.020 |
Why?
|
Haplotypes | 1 | 2008 | 642 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2007 | 196 | 0.020 |
Why?
|
Pilot Projects | 1 | 2008 | 839 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 894 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2011 | 1801 | 0.020 |
Why?
|
Proteins | 1 | 2010 | 777 | 0.020 |
Why?
|
Mice | 1 | 2019 | 11352 | 0.020 |
Why?
|
Risk | 1 | 2006 | 674 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2010 | 2705 | 0.020 |
Why?
|
RNA | 1 | 2007 | 560 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2011 | 8489 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1988 | 63 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1988 | 216 | 0.000 |
Why?
|
Acute Disease | 1 | 1988 | 826 | 0.000 |
Why?
|
Ultrasonography | 1 | 1988 | 695 | 0.000 |
Why?
|